ClinicalTrials.gg
Not yet recruitingNCT073271778wBFR_ropeUpdated Jan 8, 2026

BFR Rope Training in Male Volleyball Players

An interventional study of Blood Pressure and Muscle Strength in Volleyball, Performance and Power, sponsored by Karabuk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-08.

Sponsored by Karabuk University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 8 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Male
01

Study summary

The study will be conducted during the preparatory period of the volleyball players and will span eight weeks. Throughout this period, athletes will continue their regular volleyball training four days per week, while the experimental group (n = 10) will perform rope training with blood flow restriction (BFR) twice per week, and the control group (n = 10) will perform the same rope training without BFR. Assessments will be carried out at the beginning of the 8-week period (pre-test) and at the end of the intervention (post-test). For both groups, all exercises will target the upper-extremity muscle groups. During the study, participants will be instructed to avoid consuming any medications, engaging in additional strenuous physical activities, and using any techniques or ergogenic aids that might influence the results. In both testing sessions, a standardized warm-up protocol will be implemented, consisting of a 5-minute treadmill run at 9 km/h on a Sprint Runner device (Hoggan Health Industries, Draper, UT), followed by 3 minutes of light full-body stretching. This warm-up procedure will be applied consistently across both groups to ensure standardization.

Read the detailed description

This study aims to investigate the effects of blood flow restriction (BFR) rope training on athletic performance, muscle strength, and muscle hypertrophy in male volleyball players through an eight-week intervention. Conducted during the athletes' preparatory period, the study requires participants to perform rope-training sessions four days per week in addition to their regular volleyball training. On the first day, all athletes will undergo anthropometric measurements, and a familiarization session will be conducted to minimize potential learning effects. Participants will then be randomly assigned to either a BFR rope-training experimental group (BFR) or a control group (CON) performing standard rope training. Both groups will follow a progressive training protocol consisting of three sets and five exercises, while the BFR group will train under a cuff pressure set at 60% of limb occlusion pressure (LOP). Throughout the training sessions, heart rate, rating of perceived exertion (RPE), perceived discomfort (PD), OMNI-RES exercise difficulty, and PACES exercise enjoyment scores will be recorded. Pre- and post-intervention assessments will include ultrasound measurements of muscle thickness and cross-sectional area, one-repetition maximum (1RM) tests for biceps and triceps, upper-body strength tests (push-ups, sit-ups, and squats), shoulder strength using a Lafayette device, handgrip strength, aerobic endurance via the Yo-Yo IR1 test, anaerobic performance via the Wingate test, and volleyball serve speed measurements. All exercises will target upper-extremity muscle groups, and participants will be instructed to refrain from using any medications, ergogenic aids, or additional strenuous exercise that could influence outcomes. During both pre- and post-testing sessions, all athletes will complete a standardized warm-up protocol consisting of a 5-minute treadmill run at 9 km/h followed by 3 minutes of light full-body stretching. This comprehensive design aims to provide valuable insights into how BFR-based rope training influences performance adaptations in volleyball athletes.

02

Conditions studied

  • Volleyball
  • Performance
  • Power

Browse trials for

Keywords

  • blood flow restriction
  • rope
  • volleyball
  • hypertrophy
03

In context

Hypertrophy

139 studies on the registry are indexed under Hypertrophy; 22 are open to participants now.

This study's planned enrollment of 26 is below the median of 34 across 112 interventional studies indexed under Hypertrophy.

Browse Hypertrophy studies →

Lead sponsor

Karabuk University is the lead sponsor of 143 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being healthy
  • Male volleyball athletes
  • Willing to maintain the intervention for all sessions

Exclusion criteria

Exclusion Criteria:

  • Being under 18 years old
  • Having a chronic disease
  • for exercise
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
26 participants (estimated)

Study arms

  • Other
    Blood Pressure

    Determination of Blood Pressure

    Other: Blood Pressure

  • Experimental
    Muscle Strength

    Determination of Muscle Strength

    Other: Muscle Strength

  • Other
    Serve Speed

    Determination of Serve Speed

    Other: Serve Speed

  • Other
    Blood Flow Restriction (BFR)

    Blood Flow Restriction Protocol

    Other: Blood Flow Restriction

  • Other
    Rating of Perceived Exertion (RPE)

    Determination of Perceived Exertion

    Other: Rating of Perceived Exertion

  • Other
    Battle Rope Training

    Battle Rope Training Protocol

    Other: Battle Rope Training

  • Other
    Arm Circumference

    Arm Circumference Measurement

    Other: Arm Circumference

  • Other
    Skeletal Muscle Endurance

    Skeletal Muscle Endurance Tests (Sit-Up, Push-Up, and Pull-Up)

    Other: Skeletal Muscle Endurance

  • Other
    Anaerobic Power

    Anaerobic Power Assessment

    Other: Anaerobic Power

  • Other
    Bench Press 1RM Test

    Bench Press 1RM Test Measurement

    Other: Bench Press 1RM Test

  • Other
    Triceps Push-Down 1RM Test

    Triceps Push-Down 1RM Test Measurement

    Other: Triceps Push-Down 1RM Test

  • Other
    Hand Grip Strength Test

    Hand Grip Strength Test Measurement

    Other: Hand Grip Strength Test

  • Other
    Yo-Yo IR1 Test

    Yo-Yo IR1 Test Measurement

    Other: Yo-Yo IR1 Test

  • Other
    Ultrasound (US)

    Ultrasound (US) Measurements

    Other: Ultrasound (US)

  • Other
    Perceived Discomfort Level

    Determination of Perceived Discomfort Level

    Other: Perceived Discomfort Level

  • Other
    Exercise Enjoyment

    Exercise Enjoyment Assessment

    Other: Exercise Enjoyment

  • Other
    Perceived Exertion Level (OMNI-RES)

    Perceived Exertion Level Assessment

    Other: Perceived Exertion Level (OMNI-RES)

Interventions

  • OtherBlood Pressure

    A digital Omron device (model M2; Ankara, Turkey) will be used to measure participants' resting blood pressure. Prior to exercise, systolic, diastolic, and heart rate values will be recorded, and individuals outside the 140/90 mmHg range will be excluded. Participants will remain seated for 10 minutes, after which three measurements will be taken from the dominant arm with at least 1 minute between readings. Resting blood pressure will be calculated as the average of these three values, following American Heart Association guidelines (Pickering et al., 2005).

  • OtherMuscle Strength

    Dominant and non-dominant shoulder internal and external rotation strength will be assessed using a Lafayette digital handheld dynamometer. This portable device provides peak force, time to peak force, total test duration, and average force in kilograms, Newtons, and pounds. Participants will receive verbal instructions and complete a familiarization trial before testing. The "make test" technique will be used, in which the examiner stabilizes the device while the participant applies maximal isometric force. All measurements will be taken twice by the same trainer. Prior to testing, a 10-minute warm-up including upper-extremity and shoulder rotation movements will be performed. Participants will then lie supine on a flat surface, and dominant and non-dominant internal and external rotation strength will be measured and recorded (Kesilmiş \& Manolya, 2020).

  • OtherServe Speed

    The serve speed test will be conducted in the Hasan Doğan Sports Sciences Gymnasium at Karabük University using official balls (FIVB Beach Championship VLS300 MIKASA). Athletes will begin with a 15-minute warm-up consisting of joint mobility exercises (e.g., knee flexion/extension, shoulder rotation, ankle dorsiflexion), followed by technical movements such as ball-free jumping and running to enhance coordination. Each player will then perform ten practice serves. A total of 196 power-kick serves (28 per participant) will be recorded without opposition. After each isometric exercise, participants will execute four maximal-intensity serves, and ball speed will be determined from these attempts. Athletes will be encouraged to strike the ball with maximum force. A radar device will be positioned 8 m behind the service line and 3 m above the ground to capture serve velocity at a height consistent with ball-hand contact (Buscà et al., 2012). Serve speed will be measured using a standard ra

  • OtherBlood Flow Restriction

    The arterial occlusion pressures (AOP) of the athletes randomized to the experimental group will be automatically determined using a digital LED-display BFR device (Fit Cuffs BFR, Denmark). Optimal cuff width, occlusion pressure, and exercise procedures have been previously described in the literature (Loenneke et al., 2015; Scott et al., 2015). A 4-inch-wide tourniquet will be applied to the upper arm of the participant's dominant limb. During the exercise, the AOP will be maintained at 60% using the Fit Cuffs BFR Unit (Denmark), and consistent pressure will be applied to the limb throughout the full range of motion. All participants will use the same cuff model, and 60% AOP will be administered with an FDA/CE-approved automatic Smart Cuffs Pro device (Elite, USA), applied to the proximal region of the arm.

  • OtherRating of Perceived Exertion

    After each training session, RPE will be collected using the 6-20 Borg Scale at the end of the session, where 6 indicates "no exertion" and 20 indicates "maximal exertion" (Foster et al., 2021).

  • OtherBattle Rope Training

    Based on prior literature recommending battle ropes measuring 12-15 m in length, 3-5 cm in diameter, and 9-16 kg in weight (Pustina et al., 2017; Tessitore et al., 2006; Ziy et al., 2009), this study will use a 12-m, 3.8-cm diameter, 12-kg rope. Participants will perform wave-style rope exercises in a standing position with feet shoulder-width apart and the trunk flexed forward at approximately 30-45°. The rope will be anchored at its midpoint to a stable object, and participants will grip the ends (5 m ± 5 cm each) and execute bilateral oscillations. The protocol will include three sets of five exercises, with progressive durations across the 8-week period: 15 seconds in Weeks 1-2, 20 seconds in Weeks 3-5, and 25 seconds in Weeks 6-8. Rest intervals between sets will remain consistent at 45 seconds throughout the training program.

  • OtherArm Circumference

    Before the training session and without performing any physical activity, arm circumference will be measured using a 300-cm non-elastic measuring tape. Measurements will be taken at a 90° elbow angle from the midpoint of the upper arm, over the biceps muscle (Otman, 2003).

  • OtherSkeletal Muscle Endurance

    Upper-body and trunk muscular endurance will be assessed using standardized ACSM protocols. Upper-body endurance will be measured with the ACSM push-up test: men will perform standard push-ups, while women will complete kneeling push-ups. The test will stop at volitional fatigue or after two consecutive form errors (chin to mat and full elbow extension). Trunk endurance will be evaluated using the cadence-based YMCA bent-knee sit-up test, performed at one repetition every 2 seconds until volitional fatigue. A valid sit-up requires elbows touching the knees and returning to the starting position in cadence. Upper-body pulling endurance will be tested with a pronated-grip pull-up test. Repetitions must include the chin rising above the bar and full controlled elbow extension. The test ends at volitional fatigue or after repeated form errors. All endurance tests (push-up, sit-up, pull-up) will be performed to volitional fatigue with 2-3 minutes of rest between tests, and the same test

  • OtherAnaerobic Power

    The Wingate Anaerobic Power Test (WAnT) is a widely used 30-second cycling test designed to measure short-term, high-intensity power output and anaerobic energy system capacity (Reiser et al., 2002). Conducted on a Monark 894E ergometer, the test uses a resistance load adjusted to each participant's body mass (Jaafar et al., 2014). Before testing, participants will complete a 4-5 minute warm-up at 60-70 W and 60-70 rpm, including 2-3 short sprints, followed by 3-5 minutes of passive rest. Saddle and handlebar settings will be adjusted so the knee reaches full extension at the lowest pedal position, and feet will be secured with clips. Participants will accelerate to maximal speed without resistance; once they reach 150 rpm, the programmed resistance load will automatically engage. They will then pedal maximally for 30 seconds against this resistance while receiving verbal encouragement (Ozkan, 2007).

  • OtherBench Press 1RM Test

    Participants will begin with a 5-minute treadmill warm-up at 9 km/h followed by three minutes of light stretching (do Carmo et al., 2021). A specific warm-up will then be performed: 5 reps at 50% of estimated 1RM, followed by 1-2 sets of 2-3 reps at 60-80%. After warm-up, participants will perform single-rep attempts with gradually increasing loads to determine their 1RM, resting 3-5 minutes between trials. Up to five attempts will be used to identify the true 1RM (Schoenfeld et al., 2016).

  • OtherTriceps Push-Down 1RM Test

    Participants will stand in front of the triceps push-down machine, gripping the bar with a shoulder-width pronated grip. Throughout the exercise, the arms will be kept close to the torso, with the trunk slightly leaned forward, ensuring that the hands do not touch the body during full elbow extension. Participants will push the bar downward until reaching full elbow extension, then return to the starting position in a controlled manner; this will count as one repetition. The maximum load that each participant can successfully lift for one full repetition will be recorded as their 1RM (Hussain et al., 2020).

  • OtherHand Grip Strength Test

    A calibrated hand grip dynamometer (Takei 5101, Tokyo, Japan) will be used to evaluate maximal hand grip strength. Participants will be instructed to grasp the dynamometer with their hand while exerting maximal isometric force, maintaining extended elbows and a neutral wrist position at the lateral side of the body. The testing protocol will include two trials with a 60-second rest interval between them. The highest value obtained will be recorded as the maximal force output. Throughout the test, participants will be strongly encouraged to exert maximal effort (Lopes-Silva et al., 2022).

  • OtherYo-Yo IR1 Test

    The Yo-Yo Intermittent Recovery Level 1 (Yo-Yo IR1) test will be used to assess intermittent endurance capacity (Krustrup et al., 2003). Participants will complete 20 m shuttle runs at progressively increasing speeds, with 10 seconds of active recovery (light jogging over 2 m × 5 m) between runs. The test will stop when the participant can no longer maintain the required pace or fails to reach the line on time for two consecutive shuttles. Performance will be scored by the total distance (number of completed shuttles). A familiarization trial will be conducted before testing. The Yo-Yo IR1 demonstrates high reliability (ICC = 0.94; CV = 3.6%) (Krustrup et al., 2003).

  • OtherUltrasound (US)

    Muscle thickness and cross-sectional area (CSA) will be measured 48-72 hours after the final training session, with no prior physical activity. A blinded physician will conduct all assessments using standardized anatomical points for the biceps brachii, triceps brachii, brachialis, anterior deltoid, upper trapezius, and rectus abdominis. Measurements will be taken in the axial plane with a light, 90° probe contact. A Toshiba Aplio 500 ultrasound device (10 MHz linear probe) will be used. CSA will be calculated by tracing the inner muscle border, and muscle thickness will be measured between superficial and deep aponeuroses. Two radiology specialists will evaluate the results jointly (Kubo et al., 2011).

  • OtherPerceived Discomfort Level

    Perceived Discomfort Level (PDL) will be assessed using a scale ranging from 0 ("no discomfort") to 10 ("maximum discomfort") (Borg, 1998). The PDL will be evaluated twice: once for overall body discomfort and once specifically for arm discomfort.

  • OtherExercise Enjoyment

    Exercise enjoyment will be measured using the shortened 8-item version of the Physical Activity Enjoyment Scale (PACES), originally developed by Kendzierski and DeCarlo (1991) and later adapted by Raedeke (2007). This single-factor scale evaluates the level of enjoyment experienced during exercise. Each item is rated on a 7-point Likert scale ranging from 1 ("do not enjoy at all") to 7 ("enjoy very much"), with 4 representing a neutral midpoint. Higher scores indicate greater enjoyment derived from the physical activity (Soylu et al., 2023).

  • OtherPerceived Exertion Level (OMNI-RES)

    The OMNI-RES resistance exercise scale will be used to assess participants' perceived exertion levels. A rating will be recorded at the end of each set, and the average of all set scores will be calculated and documented at the end of the exercise session. The scale will remain within the participant's visual field throughout the session, and they will be instructed to focus on their sense of effort immediately before each rating. Using standardized definitions and instructions, participants will rate their exertion on a scale ranging from 0 ("extremely easy") to 10 ("extremely hard") (Robertson et al., 2003).

06

What researchers measure

Primary outcomes

  1. Muscle Thickness (Ultrasound) - Biceps, Triceps, Brachialis, Antrerior Deltoid, Upper Trapezius, Rectus Abdominis

    Change in muscle thickness (mm) from baseline to 8-week follow-up as measured by diagnostic ultrasound.

    Time frame: From baseline assessment to 8-week follow-up assessment

  2. Muscle Cross-Sectional Area (CSA) - Biceps, Triceps, Brachialis, Antrerior Deltoid, Upper Trapezius, Rectus Abdominis

    Change in muscle CSA (cm²) for specified muscles combined or reported individually from baseline to 8-week follow-up as measured by diagnostic ultrasound.

    Time frame: From baseline assessment to 8-week follow-up assessment.

  3. 1-Repetition Maximum (1RM) - Bench Press and Triceps Push-Down

    Change in bench Press and triceps push-down 1RM (kg) from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment.

  4. Shoulder Internal/External Rotation Strength

    Change in peak isometric rotation force (kg) for dominant and non-dominant shoulders (measured by handheld dynamometer, make test) from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  5. Hand Grip Strength

    Change in maximal handgrip strength (kg) from baseline to 8-week follow-up measured with a calibrated dynamometer

    Time frame: From baseline assessment to 8-week follow-up assessment.

  6. Upper-Body Muscular Endurance - Push-Up, Sit-Up, Pull-Up

    Change in number of repetitions to volitional fatigue for push-up, sit-up, and pull-up tests from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  7. Serve Speed

    Change in maximum volleyball serve speed (km/h) from baseline to 8-week follow-up measured by radar.

    Time frame: From baseline assessment to 8-week follow-up assessment

  8. Aerobic Intermittent Endurance - Yo-Yo IR1

    Change in Yo-Yo IR1 performance (VO2max) from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  9. Anaerobic Power - Wingate Test

    Change in peak power and mean power (W and W·kg-¹) derived from the 30-s Wingate test from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  10. Perceived Exertion - RPE (Borg 6-20)

    Change in session RPE (Borg 6-20 score), averaged across training sessions, from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  11. Perceived Discomfort (RPD)

    Change in perceived discomfort scores (0-10 scale) for whole body and arm-specific measures from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  12. Exercise Enjoyment (PACES)

    Change in exercise enjoyment score (8-item PACES, score range 1-7) from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

  13. OMNI-RES (Resistance Exercise Perceived Exertion)

    Change in OMNI-RES average score (0-10) across sessions from baseline to 8-week follow-up.

    Time frame: From baseline assessment to 8-week follow-up assessment

Secondary outcomes

  1. Anthropometric Measurements 1

    Participants' height (cm) will assess by using a stadiometer (Holtain Stadiometer, England).

    Time frame: Baseline

  2. Anthropometric Measurements 2

    Body weight (kg) will asses by Inbody 270 (Biospace, California, USA)

    Time frame: Baseline

  3. Anthropometric Measurements 3

    Body mass index (BMI) (kg/m2) will asses by Inbody 270 (Biospace, California, USA).

    Time frame: Baseline

  4. Anthropometric Measurements 4

    Body fat percentage (%) will asses by Inbody 270 (Biospace, California, USA).

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Publications

  • Kamis O, Rolnick N, de Queiros VS, Akcay N, Keskin K, Yildiz KC, Sofuoglu C, Werner T, Hughes L. Impact of limb occlusion pressure assessment position on performance, cardiovascular, and perceptual responses in blood flow restricted low-load resistance exercise: A randomized crossover trial. J Sports Sci. 2025 Oct;43(19):2256-2264. doi: 10.1080/02640414.2024.2422205. Epub 2024 Nov 10. PubMed 39523480 ↗
  • Keskin K, Akcay N, Ozmen T, Contarli N, Yildiz KC, Sofuoglu C, Kamis O, Rolnick N, de Queiros VS, Montoye A. Effects of different pre-exercise strategies on jumping performance in female volleyball players. J Sports Med Phys Fitness. 2025 Jan;65(1):59-68. doi: 10.23736/S0022-4707.24.16196-8. Epub 2024 Oct 3. PubMed 39360986 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Mar 2026, 2 months later.

Of 65 non-industry interventional studies with no phase under Hypertrophy, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 22. This study's planned 2 months is below that.

Counting every sponsor, half of 78 studies reached it within 13 months; a quarter within 6 and three quarters within 22.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2025
First posted
Jan 8, 2026
StartEst.
Dec 11, 2025
Primary completionEst.
Mar 1, 2026
CompletionEst.
Mar 5, 2026
Last update
Jan 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07327177
Lead sponsor
Karabuk University
Responsible party
Neslihan AKÇAY (Assoc. Prof. Dr., Karabuk University) — Principal investigator
First posted
Jan 8, 2026
Start date
Dec 11, 2025 (estimated)
Primary completion
Mar 1, 2026 (estimated)
Completion
Mar 5, 2026 (estimated)
Last update
Jan 8, 2026

Study contacts

Neslihan Akçay, Doctorate
Contact
neslihanozcan@karabuk.edu.tr
+905468426671
Neslihan Akçay, Doctorate
Contact
Neslihan Akçay, Doctorate
study chair · Karabuk University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion